Charter Life Sciences is a Mountain View, California based venture capital firm. They focus on clinical-stage investments in early-stage opportunities.
Their preferred investments are in biotechnology and drug development companies, especially in biologic and small molecule opportunities; medical device companies, especially therapeutic devices and diagnostic opportunities; and health care information technology companies, especially in companies focused on information access needs but not in consumer focused healthcare information technology.
Charter Life Sciences will invest in Series A or Series B rounds, with some later round financing, and their initial investment ranges from $1 million to $5 million and want board representation as a condition of investment.
Charter Life Sciences has made investments in WhiteLight Systems, KFx Medical, Kereos, Bullhorn, Amaranth Medical, CoMentis, Mirabilis Medica, APT Pharmaceutical, Prevacept Infection Control and Minimally invasive devices.
A. Barr Dolan
Andrew K. Klatt
Partner, Chief Financial Officer
Donald C. Harrison, M.D.
Gino Di Sciullo, Ph.D.
James H. Liu, MD
Jerrold M. Olefsky, MD
Nelson Teng, M.D.
Stanley N. Cohen, MD
Stuart B. Goodman, MD, PhD
Yuet W. Kan, MD